Osteoporosis, Postmenopausal - 26 Studies Found
Not yet recruiting |
: The Deferasirox-calcium-vitamin D3 Therapy for Postmenopausal Osteoporosis (PMOP) : Postmenopausal Osteoporosis : 2016-07-19 :
|
Completed |
: Study to Evaluate AMG 162 in the Prevention of Postmenopausal Osteoporosis : Postmenopausal Osteoporosis : 2004-09-17 :
|
Completed |
: Efficacy and Safety Study on Menatetrenone in the Treatment of Postmenopausal Osteoporosis Women : Postmenopausal Osteoporosis : 2005-09-12 :
|
Completed |
: Study on the microRNA Expression Level in Postmenopausal Osteoporosis : Postmenopausal Osteoporosis : 2014-03-14 : Other: osteoporosis |
Completed |
: Resolution of Effect of Bisphosphonates on Bone in Postmenopausal Osteoporosis : Postmenopausal Osteoporosis : 2011-07-29 : Other: Observation In this study we will examine the changes in bone density by DXA and QUS and bone tur |
No longer available |
: A Study of Quarterly Intravenous Bonviva (Ibandronate) in Women With Post-Menopausal Osteoporosis. : Postmenopausal Osteoporosis : 2007-06-27 : Drug: ibandronate [Bonviva/Boniva] 3mg iv every 3 months |
Completed |
: BEATRIS Study: A Study of Adherence to Bonviva (Ibandronate) Once Monthly in Women With Post-Menopausal Osteoporosis : Postmenopausal Osteoporosis : 2007-10-16 :
|
Completed |
: A Study of Adherence to Once Monthly Ibandronate (Bonviva) in Women With Post-Menopausal Osteoporosis, Supported by a Patient Relationship Program (PRP) : Postmenopausal Osteoporosis : 2007-10-16 : Drug: Ibandronate Participants will receive ibandronate 150 mg QM orally for 6 months. |
Completed |
: A Study of Ibandronate (Bonviva) in Patients With Post-Menopausal Osteoporosis : Postmenopausal Osteoporosis : 2015-11-04 :
|
Completed |
: Study To Investigate Patient Preference On Dosing In Ibandronate And Risedronate In Korean Women With Postmenopausal Osteoporosis : Postmenopausal Osteoporosis : 2006-11-29 : Drug: Ibandronate (SB743830HD) |